Clinical Trial Results

A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

PHASE2INTERVENTIONAL Irvine, California +4 more

RECRUITING

A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

PHASE3INTERVENTIONAL Phoenix, Arizona +4 more

RECRUITING

A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

PHASE2INTERVENTIONAL Phoenix, Arizona +4 more

RECRUITING

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

PHASE3INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

SAD Study of CGB3002 in Healthy Participants

PHASE1INTERVENTIONAL Melbourne, Victoria

RECRUITING

A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

PHASE2, PHASE3INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

PHASE2, PHASE3INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

A Study of LY3439539 in Participants With Alzheimer's Disease

PHASE1INTERVENTIONAL Irvine, California +4 more

RECRUITING

Dominantly Inherited Alzheimer Network (DIAN)

N/AOBSERVATIONAL Jacksonville, Florida +4 more

RECRUITING

Retinal Hyperspectral Imaging in Neurodegenerative Diseases

NAINTERVENTIONAL Melbourne, Victoria

RECRUITING

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

PHASE3INTERVENTIONAL Long Beach, California +4 more

RECRUITING

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

PHASE3INTERVENTIONAL Fullerton, California +4 more

RECRUITING